Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 27 | 2026 | 2324 | 3.750 |
Why?
|
| Brain Neoplasms | 7 | 2026 | 323 | 2.250 |
Why?
|
| Brain Mapping | 9 | 2024 | 247 | 2.220 |
Why?
|
| Glioma | 4 | 2022 | 101 | 1.960 |
Why?
|
| Meningomyelocele | 8 | 2010 | 10 | 1.650 |
Why?
|
| Neuroimaging | 7 | 2025 | 170 | 1.250 |
Why?
|
| Language Disorders | 5 | 2009 | 25 | 1.060 |
Why?
|
| Brain | 11 | 2025 | 1672 | 0.990 |
Why?
|
| Functional Neuroimaging | 1 | 2026 | 18 | 0.970 |
Why?
|
| Proton Therapy | 1 | 2026 | 12 | 0.960 |
Why?
|
| Hydrocephalus | 6 | 2005 | 41 | 0.960 |
Why?
|
| Nerve Net | 3 | 2020 | 105 | 0.900 |
Why?
|
| Cognition Disorders | 2 | 2026 | 224 | 0.870 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2026 | 1663 | 0.860 |
Why?
|
| Virus Diseases | 2 | 2016 | 118 | 0.850 |
Why?
|
| Back Pain | 1 | 2023 | 49 | 0.770 |
Why?
|
| Biomarkers | 2 | 2026 | 1503 | 0.760 |
Why?
|
| Diagnostic Imaging | 3 | 2016 | 274 | 0.750 |
Why?
|
| Sensorimotor Cortex | 1 | 2022 | 4 | 0.740 |
Why?
|
| Cerebellum | 1 | 2022 | 94 | 0.700 |
Why?
|
| Cerebral Cortex | 1 | 2022 | 276 | 0.650 |
Why?
|
| Brain Diseases | 3 | 2021 | 76 | 0.630 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 170 | 0.610 |
Why?
|
| Humans | 49 | 2026 | 65845 | 0.590 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 129 | 0.530 |
Why?
|
| Child | 18 | 2026 | 4653 | 0.500 |
Why?
|
| Social Environment | 2 | 2009 | 93 | 0.500 |
Why?
|
| Male | 34 | 2026 | 31410 | 0.500 |
Why?
|
| Parasitic Diseases | 1 | 2016 | 5 | 0.490 |
Why?
|
| Female | 33 | 2026 | 34425 | 0.490 |
Why?
|
| Laryngoplasty | 1 | 2016 | 1 | 0.480 |
Why?
|
| Vocal Cord Paralysis | 1 | 2016 | 10 | 0.480 |
Why?
|
| Mycoses | 1 | 2016 | 66 | 0.460 |
Why?
|
| Neoplasms | 2 | 2023 | 1378 | 0.460 |
Why?
|
| Language | 4 | 2024 | 155 | 0.460 |
Why?
|
| Orbit | 1 | 2015 | 18 | 0.450 |
Why?
|
| Algorithms | 3 | 2017 | 1060 | 0.450 |
Why?
|
| Bone Diseases | 1 | 2015 | 25 | 0.450 |
Why?
|
| Eye Diseases | 1 | 2015 | 37 | 0.440 |
Why?
|
| Spinal Dysraphism | 3 | 2005 | 18 | 0.440 |
Why?
|
| Family | 2 | 2009 | 250 | 0.440 |
Why?
|
| Bacterial Infections | 1 | 2016 | 151 | 0.430 |
Why?
|
| Prion Diseases | 1 | 2014 | 13 | 0.430 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 9 | 0.430 |
Why?
|
| Temperament | 2 | 2004 | 20 | 0.420 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 202 | 0.400 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2014 | 190 | 0.400 |
Why?
|
| Radiation Protection | 1 | 2013 | 27 | 0.390 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2013 | 32 | 0.390 |
Why?
|
| Case-Control Studies | 6 | 2026 | 1148 | 0.390 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 76 | 0.380 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 197 | 0.370 |
Why?
|
| Radiation Dosage | 1 | 2013 | 140 | 0.370 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 166 | 0.360 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2024 | 39 | 0.350 |
Why?
|
| Mastoid | 2 | 2026 | 7 | 0.340 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 264 | 0.340 |
Why?
|
| Critical Care | 1 | 2015 | 416 | 0.330 |
Why?
|
| Cysts | 1 | 2011 | 44 | 0.330 |
Why?
|
| Adult | 16 | 2026 | 17579 | 0.320 |
Why?
|
| Frontal Lobe | 2 | 2021 | 63 | 0.310 |
Why?
|
| Adolescent | 9 | 2026 | 6368 | 0.310 |
Why?
|
| Liver Diseases | 1 | 2011 | 157 | 0.300 |
Why?
|
| Prognosis | 5 | 2026 | 1793 | 0.300 |
Why?
|
| Ventriculoperitoneal Shunt | 3 | 2003 | 30 | 0.300 |
Why?
|
| Language Tests | 3 | 2005 | 39 | 0.290 |
Why?
|
| Stroke | 2 | 2015 | 1225 | 0.290 |
Why?
|
| Radiosurgery | 2 | 2020 | 69 | 0.280 |
Why?
|
| Child, Preschool | 9 | 2025 | 2090 | 0.280 |
Why?
|
| Cerebrospinal Fluid Shunts | 3 | 2005 | 9 | 0.260 |
Why?
|
| Middle Aged | 13 | 2026 | 18501 | 0.260 |
Why?
|
| Follow-Up Studies | 4 | 2026 | 2500 | 0.260 |
Why?
|
| Genetic Therapy | 2 | 2025 | 852 | 0.260 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2025 | 715 | 0.250 |
Why?
|
| Retrospective Studies | 9 | 2026 | 6957 | 0.250 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 172 | 0.250 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2006 | 5 | 0.240 |
Why?
|
| Bone Conduction | 1 | 2026 | 5 | 0.240 |
Why?
|
| Limbic System | 1 | 2006 | 28 | 0.240 |
Why?
|
| Temporal Bone | 1 | 2026 | 11 | 0.240 |
Why?
|
| Abnormalities, Multiple | 1 | 2006 | 54 | 0.240 |
Why?
|
| Prospective Studies | 5 | 2026 | 3340 | 0.230 |
Why?
|
| Rest | 3 | 2020 | 51 | 0.230 |
Why?
|
| Child Language | 1 | 2005 | 10 | 0.230 |
Why?
|
| Gangliosidoses, GM2 | 1 | 2025 | 18 | 0.230 |
Why?
|
| Gray Matter | 1 | 2025 | 43 | 0.220 |
Why?
|
| Sandhoff Disease | 1 | 2025 | 38 | 0.220 |
Why?
|
| Cognition | 2 | 2026 | 515 | 0.220 |
Why?
|
| Memory | 1 | 2006 | 124 | 0.220 |
Why?
|
| Neuropsychological Tests | 2 | 2026 | 420 | 0.220 |
Why?
|
| Gangliosidosis, GM1 | 1 | 2025 | 26 | 0.220 |
Why?
|
| Tay-Sachs Disease | 1 | 2025 | 55 | 0.210 |
Why?
|
| Learning | 1 | 2006 | 186 | 0.210 |
Why?
|
| Tumor Burden | 2 | 2022 | 77 | 0.210 |
Why?
|
| Parents | 2 | 2004 | 418 | 0.190 |
Why?
|
| Epilepsy | 1 | 2024 | 113 | 0.190 |
Why?
|
| Hand | 2 | 2020 | 79 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 378 | 0.180 |
Why?
|
| Body Mass Index | 1 | 2026 | 901 | 0.180 |
Why?
|
| Genetic Vectors | 2 | 2025 | 930 | 0.180 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2022 | 28 | 0.170 |
Why?
|
| Dependovirus | 2 | 2025 | 760 | 0.170 |
Why?
|
| Neck | 2 | 2018 | 47 | 0.160 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 993 | 0.150 |
Why?
|
| Cross-Sectional Studies | 2 | 2026 | 2739 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 180 | 0.150 |
Why?
|
| Contrast Media | 2 | 2020 | 435 | 0.150 |
Why?
|
| Infant | 5 | 2025 | 1718 | 0.150 |
Why?
|
| Motor Cortex | 1 | 2020 | 75 | 0.150 |
Why?
|
| Aged | 10 | 2026 | 15147 | 0.140 |
Why?
|
| Quality of Life | 1 | 2026 | 1266 | 0.140 |
Why?
|
| Thumb | 1 | 2018 | 27 | 0.140 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 6 | 0.140 |
Why?
|
| Functional Laterality | 1 | 2019 | 141 | 0.140 |
Why?
|
| Antigens, CD19 | 1 | 2018 | 25 | 0.140 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2018 | 23 | 0.140 |
Why?
|
| Young Adult | 5 | 2025 | 4883 | 0.140 |
Why?
|
| Adoptive Transfer | 1 | 2018 | 145 | 0.130 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2018 | 81 | 0.130 |
Why?
|
| Reproducibility of Results | 3 | 2025 | 1719 | 0.130 |
Why?
|
| Neural Pathways | 1 | 2018 | 105 | 0.130 |
Why?
|
| Cytokines | 2 | 2021 | 965 | 0.130 |
Why?
|
| Lymphoma | 1 | 2018 | 101 | 0.130 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2016 | 2 | 0.120 |
Why?
|
| Nose Diseases | 1 | 2016 | 7 | 0.120 |
Why?
|
| Orbital Diseases | 1 | 2016 | 10 | 0.120 |
Why?
|
| Pharyngeal Diseases | 1 | 2016 | 11 | 0.120 |
Why?
|
| Meninges | 1 | 2016 | 11 | 0.120 |
Why?
|
| Mouth Diseases | 1 | 2016 | 15 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2026 | 5682 | 0.120 |
Why?
|
| Cerebral Angiography | 2 | 2015 | 303 | 0.120 |
Why?
|
| Preoperative Care | 1 | 2017 | 199 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 186 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 71 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2018 | 301 | 0.110 |
Why?
|
| Critical Pathways | 1 | 2015 | 31 | 0.110 |
Why?
|
| Intelligence | 2 | 2005 | 51 | 0.110 |
Why?
|
| Petrous Bone | 1 | 2014 | 3 | 0.100 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2014 | 7 | 0.100 |
Why?
|
| Cochlear Nerve | 1 | 2014 | 4 | 0.100 |
Why?
|
| Ear, Inner | 1 | 2014 | 12 | 0.100 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2014 | 35 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1012 | 0.100 |
Why?
|
| Oxygen | 2 | 2018 | 323 | 0.100 |
Why?
|
| Disease Progression | 3 | 2025 | 1229 | 0.090 |
Why?
|
| Caroli Disease | 1 | 2011 | 1 | 0.090 |
Why?
|
| Hamartoma | 1 | 2011 | 12 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 712 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1172 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2010 | 2651 | 0.080 |
Why?
|
| Ileum | 1 | 2010 | 21 | 0.080 |
Why?
|
| Cell Transplantation | 1 | 2009 | 41 | 0.080 |
Why?
|
| Acidosis | 1 | 2010 | 28 | 0.080 |
Why?
|
| Urologic Surgical Procedures | 1 | 2010 | 46 | 0.080 |
Why?
|
| Survival Rate | 2 | 2024 | 849 | 0.070 |
Why?
|
| Dyslexia | 1 | 2009 | 7 | 0.070 |
Why?
|
| Intelligence Tests | 1 | 2009 | 26 | 0.070 |
Why?
|
| Language Development | 1 | 2009 | 10 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2009 | 30 | 0.070 |
Why?
|
| Colon | 1 | 2010 | 148 | 0.070 |
Why?
|
| Optic Chiasm | 1 | 2008 | 6 | 0.070 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2008 | 4 | 0.070 |
Why?
|
| Optic Nerve Diseases | 1 | 2008 | 18 | 0.070 |
Why?
|
| Optic Nerve | 1 | 2008 | 29 | 0.070 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2009 | 179 | 0.070 |
Why?
|
| Aging | 1 | 2014 | 784 | 0.070 |
Why?
|
| Nanostructures | 1 | 2009 | 187 | 0.060 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2006 | 6 | 0.060 |
Why?
|
| Fornix, Brain | 1 | 2006 | 11 | 0.060 |
Why?
|
| Red Nucleus | 1 | 2025 | 5 | 0.060 |
Why?
|
| Basal Ganglia | 1 | 2025 | 34 | 0.060 |
Why?
|
| Orientation | 1 | 2005 | 26 | 0.060 |
Why?
|
| beta-Hexosaminidase alpha Chain | 1 | 2025 | 20 | 0.060 |
Why?
|
| Self-Assessment | 1 | 2005 | 60 | 0.060 |
Why?
|
| Thalamic Nuclei | 1 | 2025 | 28 | 0.060 |
Why?
|
| Amygdala | 1 | 2025 | 85 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5834 | 0.060 |
Why?
|
| Culture | 1 | 2005 | 82 | 0.050 |
Why?
|
| Personality Assessment | 1 | 2004 | 31 | 0.050 |
Why?
|
| Atrophy | 1 | 2025 | 89 | 0.050 |
Why?
|
| White Matter | 1 | 2025 | 138 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 57 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 67 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 631 | 0.050 |
Why?
|
| Perception | 1 | 2004 | 187 | 0.050 |
Why?
|
| Attention | 1 | 2005 | 154 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 806 | 0.050 |
Why?
|
| Achievement | 1 | 2002 | 29 | 0.050 |
Why?
|
| Faculty | 1 | 2002 | 58 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 325 | 0.050 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2021 | 3 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1294 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 466 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 1117 | 0.040 |
Why?
|
| Age Factors | 1 | 2003 | 1595 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 3779 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 1569 | 0.030 |
Why?
|
| Carcinoma, Large Cell | 1 | 2018 | 5 | 0.030 |
Why?
|
| Body Water | 1 | 2018 | 16 | 0.030 |
Why?
|
| Probability | 1 | 2018 | 170 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 94 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 67 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 1122 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1030 | 0.030 |
Why?
|
| Artifacts | 1 | 2018 | 130 | 0.030 |
Why?
|
| United States | 2 | 2017 | 8189 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 183 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 2790 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2018 | 282 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 256 | 0.030 |
Why?
|
| Head | 1 | 2016 | 57 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 264 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 367 | 0.030 |
Why?
|
| Collateral Circulation | 1 | 2014 | 28 | 0.030 |
Why?
|
| Animals | 3 | 2024 | 21493 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 217 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 228 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2014 | 423 | 0.020 |
Why?
|
| Porosity | 1 | 2009 | 41 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 1439 | 0.020 |
Why?
|
| Anisotropy | 1 | 2009 | 63 | 0.020 |
Why?
|
| Membranes, Artificial | 1 | 2009 | 46 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 241 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2008 | 29 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 606 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2009 | 502 | 0.010 |
Why?
|
| Radiography | 1 | 2008 | 559 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 2005 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 1433 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 2194 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 3506 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 11185 | 0.010 |
Why?
|